]>
IRCT20171225038055N1 IRCT 2018-06-05 Sabzevar University of Medical Sciences Self Monitoring of Blood Glucose (SMBG) in elderly patients with type 2 diabetes mellitus Evaluation of the effect of Self Monitoring of Blood Glucose (SMBG) on glycosylated hemoglobin level in elderly patients with type 2 diabetes mellitus 2018-05-21 anticipated 150 Complete https://irct.ir/trial/28474 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients referred to diabetes clinic in Sabzevar will be randomly divided into two groups based on random block method and tables, Blinding description: Physicians and data collector will be unaware of self assessment. 2-3 Diabetes. Intervention 1: Intervention group: Self-assessment of blood glucose in elderly diabetic patients treated with insulin . Intervention 2: Control group: Elderly diabetic patients who do not perform self-assessment of blood glucose. Yes - There is a plan to make this available What will be shared: The mean values of glycosylated hemoglobin, demographic variables and their relationship will be shared in the final article. When: Start the access period immediately after printing the results To whom: Academic researchers Conditions: The type of analysis, method of use and results should be specified. Where to obtain: Author of the article and author of the first article assarroudia@medsab.ac.ir ariafara2@mums.ac.ir How to obtain: send mail Detailed explanation of the required data The reason for the data requirement Comments:
public atousa ariafar
Ebnesina street; Emamreza Hospital
Mashhad Iran (Islamic Republic of) 9177899191 +98 51 3802 3512 ariafara2@mums.ac.ir Mashhad University of Medical Sciences scientific Atousa Ariafar
Ebnesina street; Emamreza Hospital
Mashhad Iran (Islamic Republic of) 9177899191 +98 51 3802 3512 ariafara2@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) Type 2 diabetes agreement to participate in the research Glycosylated hemoglobin between 7 and 9% 60 years no limit Both Infection with other chronic diseases including cancer, severe renal failure, severe liver and heart failure Inflammatory diseases, including rheumatoid arthritis Major Depression Other endocrine disorders, including Cushing's Blood disorders and the need for several blood transfusion E11 Type 2 diabetes mellitus Behavior Behavior Intervention group: Self-assessment of blood glucose in elderly diabetic patients treated with insulin . Control group: Elderly diabetic patients who do not perform self-assessment of blood glucose. Glycosylated hemoglobin. Timepoint: Before the intervention, 120 days after self-assessment of blood glucose. Method of measurement: The test for hemoglobin A1c will be performed by chromatography. Sabzevar University of Medical Sciences Approved 2018-01-03 Ethics committee of Sabzevar University of Medical Sciences Asadabadi blvd; sabzevar Mashhad Razavi Khorasan Iran (Islamic Republic of)